regn1909
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Feb 12, 2019 (NCT03838731)
Timeline
Indications
Mechanism of action
- feld1INHIBITOR
feld1 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06602726 | Phase 3 | Oct 15, 2024 | Regeneron |
| NCT04981717 | Phase 3 | Jul 30, 2021 | Regeneron |
| NCT03838731 | Phase 2 | Feb 12, 2019 | Regeneron |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Regeneron | For profit | 3 | 3 | 2 | 2019 |
1 organizations
Page 1 / 1